<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>RATIONALE: Catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> is an <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">inherited disease</z:e> that predisposes to <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> and <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The disease is associated with mutations in the genes encoding for the cardiac <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptor (RyR2) and cardiac calsequestrin (CASQ2) </plain></SENT>
<SENT sid="2" pm="."><plain>CASQ2 mutations lead to a major loss of CASQ2 monomers, possibly because of enhanced degradation of the mutant protein </plain></SENT>
<SENT sid="3" pm="."><plain>The decrease of CASQ2 is associated with a reduction in the levels of Triadin (TrD) and Junctin (JnC), two proteins that form, with CASQ2 and RyR2, a macromolecular complex devoted to control of calcium release from the sarcoplasmic reticulum </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: We intended to evaluate whether <z:mp ids='MP_0001799'>viral</z:mp> gene transfer of <z:mp ids='MP_0002169'>wild-type</z:mp> CASQ2 may rescue the broad spectrum of abnormalities caused by mutant CASQ2 </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS AND RESULTS: We used an adeno-associated serotype 9 <z:mp ids='MP_0001799'>viral</z:mp> vector to express a green fluorescent protein-tagged CASQ2 construct </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty weeks after intraperitoneal injection of the vector in neonate CASQ2 KO mice, we observed normalization of the levels of calsequestrin, triadin, and junctin, rescue of electrophysiological and ultrastructural abnormalities caused by CASQ2 ablation, and lack of life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We have proven the concept that induction of CASQ2 expression in knockout mice reverts the molecular, structural, and electric abnormalities and prevents life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in CASQ2-defective catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> mice </plain></SENT>
<SENT sid="8" pm="."><plain>These data support the view that development of CASQ2 <z:mp ids='MP_0001799'>viral</z:mp> gene transfer could have clinical application </plain></SENT>
</text></document>